Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle

In recent years, the PD-1/PD-L1 axis blockade has become a very promising therapy with significant clinical benefits for multiple tumor types. However, some patients still do not respond sufficiently to PD-1/PD-L1 targeted monotherapy. Therefore, investigating the mechanism of PD-1 blockade resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Yuan, Liu, Chang, Liu, Jiaqing, Li, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954840/
https://www.ncbi.nlm.nih.gov/pubmed/32021257
http://dx.doi.org/10.2147/OTT.S239398